Labshake search
Citations for Invivogen :
1 - 50 of 197 citations for 6 9 Diphenyl 9H carbazol 3 yl 3 boronic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2019Quote: ... polyinosinic-polycytidilic acid (polyIC) at 3 and 30 ng/mL (Invivogen), type-I interferon receptor inhibitor (IFNARinh ...
-
bioRxiv - Immunology 2022Quote: ... 3′3′-cyclic-di-AMP (3′3′ CDA) (Invivogen, cat. no. tlrl-nacda), 2′3′-RR c-di-AMP (2′3′-RR-S2 CDA ...
-
Nucleic acid sensing by STING induces an interferon-like antiviral response in a marine invertebratebioRxiv - Immunology 2022Quote: ... 3′3′-cGAMP (100 μM; InvivoGen), c-di-AMP (100 µM ...
-
bioRxiv - Molecular Biology 2020Quote: ... Disease was induced between 6 and 10 weeks of age using 3 mg curdlan (InvivoGen) administered by intraperitoneal injection ...
-
bioRxiv - Cell Biology 2022Quote: ... 3- methyladenine (Invivogen), bafilomycin A1 (Invivogen) ...
-
bioRxiv - Immunology 2023Quote: ... with 50 μg of the Toll-like receptor (TLR)3 agonist polyinosinic-polycytidylic acid [poly (I:C)] (InvivoGen), 50 μg of the TLR7 agonist imiquimod (InvivoGen) ...
-
bioRxiv - Cell Biology 2019Quote: ... 2’,3’-cGAMP (Invivogen) at 10 μg/mL ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP) (Invivogen cat. no. tlrl-nacga23), and human IFN-β (PeproTech ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′-RR c-di-AMP (2′3′-RR-S2 CDA) (Invivogen cat. no. tlrl-nacda2r), 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP ...
-
bioRxiv - Immunology 2022Quote: ... HEK293T cells were seeded as 0.3*106 cells in 6-wells plate followed by treatment for 4 h with 333 nM of Torin 1 (InvivoGen) alone or in combination with 200 nM of Bafilomycin A1 for 1 h.
-
bioRxiv - Microbiology 2021Quote: ... and puromycin (3 ug/mL) (InvivoGen). All cell lines were grown at 37°C in 5% CO2.
-
bioRxiv - Immunology 2022Quote: ... and puromycin (3 μg/mL) (InvivoGen). IFNAR KO A549 cells were generated by CRISPR-Cas9 ribonucleoprotein (RNP ...
-
bioRxiv - Biochemistry 2021Quote: ... 3 µg/ml Blasticidin S (InvivoGen) and 0.5 µg/ml Puromycin (Gibco ...
-
bioRxiv - Cell Biology 2023Quote: ... and 3 μg/mL puromycin (Invivogen). For immunoblotting experiments ...
-
bioRxiv - Immunology 2023Quote: ... 2′-3′cGAMP was from InvivoGen, human recombinant sTREM2 was from Sino Biological ...
-
bioRxiv - Immunology 2021Quote: ... or 2’-3’cGAMP (4µg/ml, Invivogen) for the specified times ...
-
bioRxiv - Immunology 2022Quote: ... 3 μg/mL puromycin (Invivogen, CA, USA) and 0.1 mg/mL Normocin (Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... a toll-like receptor 3 agonist (InvivoGen). Peptide doses of 50 ...
-
bioRxiv - Cell Biology 2022Quote: ... Selection with Puromicin (3 μg/ml; InvivoGen) started 72 h post infection ...
-
bioRxiv - Immunology 2024Quote: ... or 2µg/mL 2’,3’-cGAMP (InvivoGen), or 2µg/mL poly(I:C ...
-
bioRxiv - Immunology 2023Quote: ... 3 hours before infection Pam3CSK4 (Invivogen, tlrl-pms) was spiked into the wells at a final of 100 ng/mL ...
-
bioRxiv - Immunology 2020Quote: ... for 3 days with 0.5 μg/mL LPS (Invivogen) and 0.5 μg/mL anti-IgM F(ab’)2 (Jackson ImmunoResearch) ...
-
bioRxiv - Bioengineering 2022Quote: ... (3) LPS and 150 μg/ml Polymyxin B (Invivogen) for 45 and 90 min ...
-
bioRxiv - Immunology 2022Quote: ... which were selected by blasticidin (3 μg/ml, InvivoGen) for 4 days prior to the experiments.
-
bioRxiv - Systems Biology 2021Quote: ... 2’,3’-cyclic GMP-AMP (cGAMP) (Invivogen #tlrl-nacga23-5) at a concentration of 1 mg/mL (final concentration in the well 100 ug/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were exposed to puromycin (3 μM final concentration, Invivogen) for 5 minutes or left untreated for control conditions ...
-
bioRxiv - Immunology 2023Quote: ... we immunized three groups of C57BL/6 mice (n=9) with 5 µg protein antigens adjuvanted with 500 µg alum (Alhydrogel®, Invivogen) and 20 µg CpG (ODN 1826 ...
-
bioRxiv - Molecular Biology 2021Quote: ... Calu-3 (ACE2) cells further received 0.5 μg/ml puromycin (Invivogen). A549-ACE2 (Hoffmann et al. ...
-
bioRxiv - Immunology 2021Quote: ... 2’-3’-cGAMP and c-di-UMP were purchased from Invivogen. EFV was purchased from Bristol-Myers Squibb.
-
Nucleic acid sensing by STING induces an interferon-like antiviral response in a marine invertebratebioRxiv - Immunology 2022Quote: ... Elution was performed with free 2′3′-cGAMP (100 μM; InvivoGen), 3′3′-cGAMP (100 μM ...
-
bioRxiv - Immunology 2024Quote: ... and 3 μg mL−1 puromycin (InvivoGen, cat. no. ant-pr). Expi293F cells were maintained in Expi293 media in a shaking incubator at 37°C and 8% CO2.
-
bioRxiv - Immunology 2021Quote: ... was mixed with an Al (OH)3 adjuvant (Alhydrogel®, InvivoGen, France) and used as a candidate vaccine against SARS-CoV-2 ...
-
bioRxiv - Immunology 2020Quote: ... the medium was supplemented with 3 μM puromycin (InvivoGen, #ant-pr-1). Then ...
-
bioRxiv - Cell Biology 2023Quote: ... 4 µM digitonin) with or without 7 µM 2’,3’-cGAMP (Invivogen). Cells were further washed in PBS and incubated in culture medium until collection ...
-
bioRxiv - Cancer Biology 2021Quote: ... Cells were treated with 3 μg/ml plasmocin (Invivogen, San Diego, CA, USA) to prevent mycoplasma contamination ...
-
bioRxiv - Genetics 2019Quote: ... For stable sgRNA and shRNA expression 3 days puromycin (2 μg/ml, Invivogen) selection was applied.
-
bioRxiv - Cancer Biology 2020Quote: ... Transduced cells were selected for 3 weeks using puromycin (5 μg/mL,-InvivoGen).
-
bioRxiv - Immunology 2022Quote: ... and with 3 μg/ml TLR7 agonist imiquimod (InvivoGen, San Diego, CA, USA) for 3 days ...
-
bioRxiv - Immunology 2023Quote: ... The Class B CpG ODN2006 (ODN 7909, PF_3512676, sequence: 5’-tcgtcgttttgtcgttttgtcgtt-3’, Invivogen) was diluted in sterile endotoxin-free water ...
-
Increased dosage of wild-type KRAS protein drives KRAS-mutant lung tumorigenesis and drug resistancebioRxiv - Cancer Biology 2024Quote: ... Infected cells were selected using puromycin for 3 days (2 µg/ml, InvivoGen) or hygromycin B for 7 days (500 µg/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... infected cells were selected with medium containing 3 μg/ml puromycin medium (Invivogen, CA) for 4 days and resulting heterogenous pools were used for functional assays ...
-
bioRxiv - Immunology 2021Quote: ... and incubated for 3 hours in the presence of LPS (10 ng/ml, Invivogen). Primary monocytes were then treated for 1 h 30 with nigericin (5 μM ...
-
bioRxiv - Biophysics 2023Quote: ... MEFs stably expressing Skylan-NS–LC3B were selected with 3 µg/mL puromycin (Invivogen), seeded on a glass slide coated with 0.3 mg/ml collagen (Nitta Gelatin ...
-
bioRxiv - Biophysics 2023Quote: ... Cell culture media was supplemented with 3 µg/ml puromycin (InvivoGen, San Diego, USA). As a control ...
-
bioRxiv - Immunology 2020Quote: ... plus 9 μg/mL purified OVA (InvivoGen, USA) in 500 μL supplemented RPMI ...
-
bioRxiv - Immunology 2020Quote: ... plus 9 μg/mL purified OVA (InvivoGen, USA) in 500 μL complete RPMI ...
-
bioRxiv - Microbiology 2019Quote: ... Transduced cells were then selected with both 3 μg/mL puromycin (InvivoGen #ant-pr-1) and 10 μg/mL blasticidin (InvivoGen #ant-bl-1 ...
-
bioRxiv - Immunology 2020Quote: ... Cells were treated with 12.5 or 25 μg/mL 2’-3’cGAMP (Invivogen tlrl-nacga23) for 2 hr as indicated ...
-
bioRxiv - Immunology 2023Quote: ... The Class C CpG ODN_2395 sequence (5’-TCGTCGTTTTCGGCGCGCGCCG-3’) was obtained from Invivogen (#tlrl-2395). We used the crystal structure of mouse TLR9 extracellular domain (TLR9 ECD ...
-
bioRxiv - Cancer Biology 2021Quote: ... 6-8 weeks old CM knock-in mice were injected intraperitoneally with polyinosinic–polycytidylic acid [poly (I:C)] (InvivoGen, tlrl-picw-250) at 14 mg/kg/dose every other day for a total of 7 doses ...